Pricing Log in Create free account

Bolt Biotherapeutics, Inc. (BOLT) vs CNS Pharmaceuticals, Inc. (CNSP)

Bolt Biotherapeutics, Inc. and CNS Pharmaceuticals, Inc. are both Biotechnology companies. Bolt Biotherapeutics, Inc. and CNS Pharmaceuticals, Inc. are of similar size ($8.2M and $7.9M). CNS Pharmaceuticals, Inc. has the higher net margin (0.00% vs −611.5%) and the higher return on invested capital (0.00% vs −143.8%). Across the 14 metrics below, CNS Pharmaceuticals, Inc. leads on 9 and Bolt Biotherapeutics, Inc. on 5.

Valuation

Metric BOLT CNSP Biotechnology median
P/E n/m n/m 8.50
P/S 1.46 n/m 9.71
P/B 0.54 1.82 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.62 n/m 9.21
Earnings yield (404.93%) (486.39%) (33.15%)
Free cash flow yield (448.90%) (40.54%) (25.50%)

Profitability

Metric BOLT CNSP Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (654.53%) 0.00% 0.00%
Net margin (611.47%) 0.00% 0.00%
Free cash flow margin (655.72%) 0.00% 0.00%
Return on equity (111.65%) (106.62%) (56.36%)
Return on assets (49.62%) (91.64%) (48.04%)
Return on invested capital (143.75%) 0.00% 0.00%

Growth

Metric BOLT CNSP Biotechnology median
Revenue growth (TTM) 12.79% — 6.02%
EPS growth (last fiscal year) 45.91% 92.34% 30.26%
Revenue growth, 5-year CAGR 101.61% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BOLT CNSP Biotechnology median
Debt to equity 1.47 0.00 0.00
Current ratio 2.61 5.86 4.72
Net debt to EBITDA 0.21 0.45 0.96

Dividend

Metric BOLT CNSP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BOLT CNSP Biotechnology median
Market cap 8.17m 7.88m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack